医学
内科学
间质性肺病
危险系数
入射(几何)
比例危险模型
累积发病率
炎症性肠病
共病
队列研究
队列
相伴的
疾病
流行病学
丹麦语
风险评估
风险因素
回顾性队列研究
死亡风险
前瞻性队列研究
疾病严重程度
克罗恩病
死亡率
年轻人
体质指数
优势比
作者
Jonas Aggerholm Bækdal,Erik Sören Halvard Hansen,Howraman Meteran,Charlotte Suppli Ulrik,Flemming Bendtsen,Kjell Erik Julius Håkansson,Nicklas Brustad,Peter Ascanius Jacobsen,Johan M. Burisch,Elisabeth M. Bendstrup
标识
DOI:10.1093/ecco-jcc/jjag096
摘要
BACKGROUND: Extra-intestinal manifestations of inflammatory bowel disease (IBD) are well-recognized, but the long-term risk of developing interstitial lung disease (ILD) in IBD and its impact on mortality remain poorly understood. We aimed to assess the risk of ILD in patients with IBD and the subsequent effect on survival. METHODS: This nationwide cohort study (1978-2022) utilized the Danish National Patient Registry, including 53 591 patients with IBD and 267 955 age- and sex-matched controls. Adjusted hazard ratios (aHRs) were estimated using Cox regression, adjusted for age, sex, education, and Charlson Comorbidity Index (CCI). Cumulative incidence was assessed via the Aalen-Johansen estimator. Mortality in patients with comorbid IBD-ILD was analyzed using Cox regression and Kaplan-Meier curves. RESULTS: The 45-year cumulative incidence of ILD was 2.1% for IBD versus 0.9% for controls (P < .001), and aHR was 2.1 (95% CI, 1.8-2.4). Furthermore, the aHR was 3.0 (95% CI, 2.2-4.1) in patients with frequent IBD-related hospitalizations compared to matched controls. The 5-year mortality in concomitant IBD and ILD was 29.3% (95% CI, 23.3-35.3) compared to 11.9% (95% CI, 9.8-14.0) for matched patients with only IBD. Male sex and higher CCI were independent risk factors for both ILD and mortality (all P < .001). CONCLUSION: IBD is associated with a two-fold increase in ILD risk. Risk factors may include old age, longstanding disease, male sex, and comorbidity. Comorbid IBD-ILD increases mortality substantially compared to only IBD, highlighting the need for clinical awareness and early detection to improve outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI